MedElevator Войти в исследования
← Поиск публикаций

DOI 10.34067/kid.0000000838

Медицинская библиотека · Kidney360 · 2025

A Metabolomics Approach To Identify Metabolites Associated with Uremic Symptoms in Patients Receiving Maintenance Hemodialysis.

Al Awadhi Solaf, Myint Leslie, Guallar Eliseo, Clish Clary B, Wulczyn Kendra E, Kalim Sahir, Thandhani Ravi, Segev Dorry L, McAdams-DeMarco Mara, Moe Sharon M, Moorthi Ranjani N, Himmelfarb Jonathan, Powe Neil R, Tonelli Marcello, Rhee Eugene P, Shafi Tariq

СтатьяПеревод в очереди

Аннотация

KEY POINTS: Uremic symptoms are common in patients with kidney failure, but the chemicals causing them are unknown. We used state-of-the-art untargeted metabolomics and rigorous analyses to search for metabolites associated with uremic symptoms. We identified metabolite-symptom associations but could not replicate findings and offer recommendations for future research.

BACKGROUND

The specific toxins causing uremic symptoms (nausea, vomiting, pruritus, fatigue, difficulty concentrating, and pain) in kidney failure remain unknown. We used untargeted metabolomics to identify plasma metabolites associated with uremic symptoms in patients receiving hemodialysis.

METHODS

We measured metabolites in plasma samples from Longitudinal US/Canada Incident Dialysis study participants at baseline (discovery; n=636) and year 1 (internal validation; n=260) and from Frailty Assessment in Renal Disease study participants (external validation; n=355). We used metabolite-wise linear models with empirical Bayesian inference to evaluate the association between metabolites and uremic symptom severity, adjusting for key covariates. We accounted for multiple testing using a false discovery rate (P values adjusted for false discovery rate [pFDR]) for linear models and used two machine learning models to evaluate the association consistency. We defined association as significant if pFDR < 0.1 and consistent if it had medium or high importance in both machine learning models.

RESULTS

Participants had a mean age of 63 years, with uremic symptom prevalence ranging from 44% to 83%. We identified 627 previously characterized (known) and 35,558 unknown metabolite peaks. No known metabolites were significantly and consistently associated with uremic symptom severity across all cohorts. Within cohorts, retinol was negatively associated with nausea/vomiting in Longitudinal US/Canada Incident Dialysis at year 1, and indole-3-propionic acid was negatively associated with anorexia in Frailty Assessment in Renal Disease. Several unknown metabolites were associated with symptoms (lowest pFDR, 0.0004), but none were consistent across cohorts.

CONCLUSIONS

We identified metabolites associated with uremic symptom severity, although findings were inconsistent across cohorts. This study highlights the need for additional research on uremic toxins and clinical outcomes.

Для цитирования: Al Awadhi Solaf, Myint Leslie, Guallar Eliseo, Clish Clary B, Wulczyn Kendra E, Kalim Sahir, Thandhani Ravi, Segev Dorry L, McAdams-DeMarco Mara, Moe Sharon M, Moorthi Ranjani N, Himmelfarb Jonathan, Powe Neil R, Tonelli Marcello, Rhee Eugene P, Shafi Tariq. A Metabolomics Approach To Identify Metabolites Associated with Uremic Symptoms in Patients Receiving Maintenance Hemodialysis.. Kidney360. 2025. DOI: 10.34067/kid.0000000838.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.